| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.30▼ | 1.31▼ | 1.31▼ | 1.33▲ | 1.18▲ |
| MA10 | 1.33▼ | 1.33▼ | 1.30▼ | 1.26▲ | 1.27▲ |
| MA20 | 1.32▼ | 1.26▲ | 1.23▲ | 1.16▲ | 1.63▼ |
| MA50 | 1.24▲ | 1.17▲ | 1.12▲ | 1.29▲ | 1.47▼ |
| MA100 | 1.14▲ | 1.12▲ | 1.14▲ | 1.62▼ | 1.16▲ |
| MA200 | 1.14▲ | 1.24▲ | 1.34▼ | 1.56▼ | 3.21▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.012▼ | -0.003▼ | 0.001▲ | 0.042▲ | -0.062▼ |
| RSI | 47.685▼ | 54.137▲ | 57.227▲ | 59.603▲ | 46.834▼ |
| STOCH | 0.000▼ | 51.206 | 59.364 | 82.127▲ | 26.625 |
| WILL %R | -100.000▼ | -53.333 | -51.064 | -8.818▲ | -63.101 |
| CCI | -143.590▼ | -19.554 | 14.729 | 113.897▲ | -29.192 |
|
Monday, April 28, 2025 06:08 AM
TEL AVIV - Chemomab Therapeutics, Ltd. (NASDAQ:CMMB), a biotech firm focused on fibro-inflammatory diseases with a market capitalization of $24.7 million, has reported significant findings from its ...
|
|
Monday, April 28, 2025 05:00 AM
New Analyses of PSC Data from Phase 2 SPRING Trial Show that Treatment with Nebokitug Is Associated with Dose-Dependent and Significant Improvements in Multiple Inflammatory and Fibrotic Biomarkers Fu ...
|
|
Monday, April 28, 2025 01:06 AM
TEL AVIV - Chemomab Therapeutics, Ltd. (NASDAQ:CMMB), a biotech firm focused on fibro-inflammatory diseases with a market capitalization of $24.7 million, has reported significant findings from ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 1.36 | 1.381 | 1.34 | 1.37 | 57,200 |
| 30/04/25 | 1.2801 | 1.35 | 1.235 | 1.35 | 58,621 |
| 29/04/25 | 1.375 | 1.375 | 1.275 | 1.275 | 89,055 |
| 28/04/25 | 1.40 | 1.41 | 1.32 | 1.34 | 292,903 |
| 25/04/25 | 1.29 | 1.35 | 1.2807 | 1.31 | 63,234 |
| 24/04/25 | 1.21 | 1.29 | 1.20 | 1.29 | 134,752 |
| 23/04/25 | 1.18 | 1.2604 | 1.18 | 1.20 | 113,524 |
| 22/04/25 | 1.17 | 1.21 | 1.1001 | 1.17 | 69,212 |
| 21/04/25 | 1.11 | 1.175 | 1.08 | 1.16 | 78,746 |
| 17/04/25 | 1.17 | 1.1899 | 1.10 | 1.12 | 43,085 |
|
|
||||
|
|
||||
|
|